Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 22
Healthy volunteers: yes

Brief summary:
The trial will be performed as an open-label, randomised, single-dose, two-sequence crossover design for the assessment of effect of food on bioavailability of empagliflozin / linagliptin fixed dose combination (FDC) tablet.

Detailed description:

Arms:
arm 1: empagliflozin/linagliptin fixed-dose combination (FDC) film-coated tablet

Interventions: intervention 1: empagliflozin/linagliptin FDC
Intervention descriptions: intervention 1: empagliflozin/linagliptin fixed-dose combination (FDC) film-coated tablet

Protocol document: